QC
IBIO icon

Quadrature Capital’s iBio IBIO Stock Holding History

Quadrature Capital’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,850
Closed -$116K – 1232
2025
Q1 		$116K Buy
+28,850
New +$112K ﹤0.01% 923

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's IBIO Position: Q2 2025 in Review

Quadrature Capital sold out of iBio (IBIO) in Q2 2025, closing a stake of 28,850 shares — an estimated $116K sold.

Quadrature Capital first reported a position in IBIO in Q1 2025 and held it in 1 quarter. The position peaked at $116K in Q1 2025. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Quadrature Capital reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Quadrature Capital sold 28,850 iBio shares in Q2 2025, an estimated $116K.
  • Quadrature Capital first reported a position in iBio in Q1 2025 and held it in 1 quarter.
  • Quadrature Capital's iBio position peaked at $116K in Q1 2025.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.